Nebenwirkungen · Talvey
TALVEY 2 mg/mL solution for injection TALVEY 40 mg/mL solution for injection · Abschnitt 4.8 · PDF-Seite 15–16
HOS-149952 · Präparat HOS-100181
15 Skin reactions In MonumenTAL-1 (N=339), the majority of rash cases were Grade 1 or 2, with Grade 3 events occurring in 3.5% of patients. The median time to onset from the first treatment dose for rash was 22 days. The majority of non-rash skin toxicities were Grade 1 or 2, with Grade 3 pruritus occurring in 0.3% of patients. Nail disorders occurred in 56% of patients and were Grade 1 or 2. See section 4.4 for management guidance.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-28T12:44:00Z · SHA-256 2db8cb29131bf5ad5bfa5590d55b1abef557c3941c8f7475ec970bc9696fe47f · Passage f6653cc0f0406c405372d73034810fb850ee0153366f1e7fee88a57b48c585cd · Zeichen 15769–16206 im Abschnitt